Metraipolis › archive › dc_45bd0440c183
Triple-M Overlap Syndrome Associated with Immune Checkpoint Inhibitors: A FAERS Pharmacovigilance Analysis — Europe PMC PMID:42278719
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42278719
- DOI
- 10.3390/healthcare14111466
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-01T07:19:39.068Z
- SHA-256 of the archived text
6b53d22d0d58eea161b4c7780f05cb8b8ab701e3c19fa0a953623faccce7f34c- Stable URL of this page
https://metraipolis.com/documento/dc_45bd0440c183
How to cite
Triple-M Overlap Syndrome Associated with Immune Checkpoint Inhibitors: A FAERS Pharmacovigilance Analysis — Europe PMC PMID:42278719 — Europe PMC (en), https://europepmc.org/article/MED/42278719 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_45bd0440c183 (Metraipolis archive dc_45bd0440c183, sha256 6b53d22d0d58eea161b4c7780f05cb8b8ab701e3c19fa0a953623faccce7f34c)
BibTeX
@misc{dc45bd0440c183,
title = {Triple-M Overlap Syndrome Associated with Immune Checkpoint Inhibitors: A FAERS Pharmacovigilance Analysis — Europe PMC PMID:42278719},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42278719},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_45bd0440c183; sha256 6b53d22d0d58eea161b4c7780f05cb8b8ab701e3c19fa0a953623faccce7f34c},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42278719. Agents can read the archived copy with the MCP tool read_document.